Background: B-cell differentiation and B-cell tolerance checkpoints may be different in antiphospholipid syndrome (APS) from systemic lupus erythematosus (SLE) and can help to understand differences between them. Our aim was to define alterations of B-cell subsets in patients with primary APS (pAPS) and to compare them with SLE patients and healthy controls (HC). Methods: Cross-sectional study including three study groups: 37 patients with pAPS, 11 SLE patients, and 21 age- and gender-matched HC. We determined the frequencies of different B-cell subsets in peripheral blood naïve and memory compartments. In addition, we measured serum B cell-activating factor (BAFF) levels and circulating pro-inflammatory cytokines, such as IL-6, by commerci...
AbstractIntroductionCD4+CD25+Foxp3+ regulatory T (Treg) cell depletion has been reported in sys- tem...
OBJECTIVE: To analyze the clinical and immunologic manifestations of antiphospholipid syndrome (APS)...
OBJECTIVE: To analyze the clinical and immunologic manifestations of antiphospholipid syndrome (A...
Background: B-cell differentiation and B-cell tolerance checkpoints may be different in antiphosphol...
Background: B-cell differentiation and B-cell tolerance checkpoints may be different in antiphosphol...
Primary antiphospholipid syndrome (PAPS) is a systemic autoimmune disease characterized by thrombosi...
Introduction: The role of the immune response in the pathogenesis of antiphospholipid syndrome (APS)...
Systemic lupus erythematosus (SLE) is a chronic relapsing autoimmune disease that predominantly affe...
A variety of cell surface markers are being used to identify B cell subpopulations in peripheral blo...
Introduction: The role of the immune response in the pathogenesis of antiphospholipid syndrome (APS)...
Introduction: The role of the immune response in the pathogenesis of antiphospholipid syndrome (APS)...
Primary antiphospholipid syndrome (PAPS) and antiphospholipid syndrome associated to lupus (SAPS) ha...
OBJECTIVES: Incomplete SLE (iSLE) patients display symptoms typical for SLE but have insufficient cr...
Systemic lupus erythematosous (SLE) is an autoimmune disease with an important clinical and biologic...
Primary antiphospholipid syndrome (PAPS) and antiphospholipid syndrome associated to lupus (SAPS) ha...
AbstractIntroductionCD4+CD25+Foxp3+ regulatory T (Treg) cell depletion has been reported in sys- tem...
OBJECTIVE: To analyze the clinical and immunologic manifestations of antiphospholipid syndrome (APS)...
OBJECTIVE: To analyze the clinical and immunologic manifestations of antiphospholipid syndrome (A...
Background: B-cell differentiation and B-cell tolerance checkpoints may be different in antiphosphol...
Background: B-cell differentiation and B-cell tolerance checkpoints may be different in antiphosphol...
Primary antiphospholipid syndrome (PAPS) is a systemic autoimmune disease characterized by thrombosi...
Introduction: The role of the immune response in the pathogenesis of antiphospholipid syndrome (APS)...
Systemic lupus erythematosus (SLE) is a chronic relapsing autoimmune disease that predominantly affe...
A variety of cell surface markers are being used to identify B cell subpopulations in peripheral blo...
Introduction: The role of the immune response in the pathogenesis of antiphospholipid syndrome (APS)...
Introduction: The role of the immune response in the pathogenesis of antiphospholipid syndrome (APS)...
Primary antiphospholipid syndrome (PAPS) and antiphospholipid syndrome associated to lupus (SAPS) ha...
OBJECTIVES: Incomplete SLE (iSLE) patients display symptoms typical for SLE but have insufficient cr...
Systemic lupus erythematosous (SLE) is an autoimmune disease with an important clinical and biologic...
Primary antiphospholipid syndrome (PAPS) and antiphospholipid syndrome associated to lupus (SAPS) ha...
AbstractIntroductionCD4+CD25+Foxp3+ regulatory T (Treg) cell depletion has been reported in sys- tem...
OBJECTIVE: To analyze the clinical and immunologic manifestations of antiphospholipid syndrome (APS)...
OBJECTIVE: To analyze the clinical and immunologic manifestations of antiphospholipid syndrome (A...